Atlas Trials

Superselective Adrenal Arterial Embolization for Bilateral Idiopathic Hyperaldosteronism: A Prospective Cohort Study

Clinical trial NCT05186675 · UNKNOWN

Trial details

NCT number
NCT05186675
Sponsor
Second Affiliated Hospital of Nanchang University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
Start date
2022-01-01
Primary completion
2022-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.